申请人:Norton Richard L.
公开号:US09308162B2
公开(公告)日:2016-04-12
The present invention relates to biocompatible oligomer-polymer compositions for the in situ formation of implants, wherein the implants release a bioactive agent, a metabolite, or a prodrug thereof, at a controlled rate. The sustained release delivery system includes a flowable composition containing a bioactive agent, a metabolite, or a prodrug thereof, and an implant containing a bioactive agent, a metabolite, or a prodrug thereof. The flowable composition may be injected into tissue whereupon it coagulates to become the solid or gel, monolithic implant. The flowable composition includes a biodegradable, thermoplastic polymer, a biocompatible end-capped oligomeric liquid, and a bioactive agent, a metabolite, or a prodrug thereof.
本发明涉及生物相容性寡聚物-聚合物组合物,用于原位形成植入物,其中植入物以受控速率释放生物活性剂、代谢物或其前药。持续释放输送系统包括含有生物活性剂、代谢物或其前药的可流动组合物,以及含有生物活性剂、代谢物或其前药的植入物。可将可流动组合物注入组织中,使其凝结成为固体或凝胶、单体植入物。可流动组合物包括可生物降解的热塑性聚合物、生物相容性末端封端的寡聚物液体,以及生物活性剂、代谢物或其前药。